A score on this site describes public pages on one date. Pages change, so scores change. This page is the single record of every score change: which program, which criterion, the old and new scores, the date, and the page that justified the move. Each evaluation also carries its own change log at the foot of the page. Nothing is changed silently.
How a re-evaluation works
The procedure is in how we evaluate. In short: a re-check re-reads the whole reading list in Step 1 for that program, not just the page that was reported, because a pricing change often moves a refund term too. Each criterion is scored again from scratch against the written level definitions on the rubric page. Where two definitions fit, the lower is used. A second reader checks every changed row. The evaluation page's rubric table, summary, source access dates and read date are updated, the entry below is written, and the old scores stay visible here permanently.
Anyone can trigger a re-check by emailing hello@formblends.com with the URL that changed. Evaluated companies and readers are handled the same way. A definition change to the rubric itself would bump the rubric version and re-score every program; that has not happened, and the version is still 1.0.
2026-09-05, fourth read: FormBlends, 18 to 19 of 24
What FormBlends published. Later again on September 5, 2026: the cost calculator's FormBlends card now reads from the pricing module ("$190/mo, First month $99"; no $199 figure on the page); the compounded GLP-1 cash price index and its JSON feed carry two FormBlends rows sourced "formblends.com/pricing, verified 2026-09-05" (semaglutide $99 then $190; tirzepatide $149 then $239; shipping included, labs not) and score FormBlends 90 of 100; and, by FormBlends' own account, a sweep rewrote 4,501 stored article bodies (the "$199/month all-inclusive" sentence, 980 "From $299/mo" chart rows, "$149/month" and "$349" FormBlends claims, footers, annual totals) and a second sweep rewrote 2,974 bodies that had described its pharmacy as 503B, PCAB-accredited or an FDA-registered outsourcing facility.
What we re-read, and how. All 24 pages in the evaluation's source list at about 21:47 UTC (only the calculator, the cash price index and the vs-Ro article had changed since the third read). The FormBlends-vs-Ro live page was freshly rendered (cache age 39 seconds) and matched its stored body. We read the stored bodies of the articles we had cited on the third read (NEW-00024 formblends-vs-ro, form-blends-vs-ro-body, ART-06131 full comparison, NEW-00202 hims-vs-ro-vs-found, NEW-00207 formblends-vs-hims-vs-ro) and the two experience-hub FormBlends-vs-Ro bodies. We did not read the other several thousand rewritten bodies.
| Criterion | Third read | Fourth read | Page | The sentence that satisfies the level, or the element still missing |
|---|---|---|---|---|
| Licensure and state coverage | 2 | 2 | formblends.com/where-we-serve; formblends.com/pharmacy-and-quality | Unchanged pages. Held at 2: Recess MD LLC is named but no page gives its state of licensure or a licence reference. Same reading that holds Ro at 2. |
| Prescriber model | 1 | 1 | formblends.com/pharmacy-and-quality | Unchanged. Held at 1. |
| Pharmacy sourcing transparency | 3 | 3 | formblends.com/pharmacy-and-quality; stored bodies sampled | Level 3 already met on the pharmacy page. The 503B descriptions in the sampled article bodies are now 503A, except NEW-00207 formblends-vs-hims-vs-ro, which still reads Their 503B pharmacy partnerships and says FormBlends offers both compounded and brand-name options; the how-it-works page still says a licensed pharmacy or FDA-registered outsourcing facility. Residuals noted, score unchanged. |
| Pricing transparency | 2 | 3 | formblends.com/pricing; formblends.com/tools/cost-calculator; formblends.com/report/data/glp1-cash-price-index; formblends.com/articles/comparison-hub/formblends-vs-ro (live and stored) | Level 3 sentence, pricing page: The price does not change with dose: it is the same at 2.5 mg or 15 mg. Your clinician sets the dose. Shipping is included; lab work is not. With Prices approved July 12, 2026, the one-time and Subscribe & Save renewal price per plan and the inclusions list, every element of the definition is on the page. The four pages held against it on the third read now agree: calculator Planning Estimate FormBlends Compounded Semaglutide $190/mo First month $99; vs-Ro Starting Price $99 first month, then $190/month and chart row First month $99 (semaglutide) or $149 (tirzepatide), then $190 or $239 per month; cash price index rows verified 2026-09-05. Residual: the shipping page still says any applicable shipping costs will be disclosed during the relevant checkout, and the index's finding 3 still lists FormBlends among providers with conflicting still-indexed pages. |
| Refund and cancellation terms | 3 | 3 | formblends.com/returns | Unchanged. |
| Medication supply chain and COA availability | 2 | 2 | formblends.com/pharmacy-and-quality | Unchanged. COA on request; laboratory not named. |
| Support access | 2 | 2 | formblends.com/contact | Unchanged. No phone or live option. |
| Privacy | 3 | 3 | formblends.com/privacy | Unchanged. |
Totals. 18 of 24 on the third read; 19 of 24 on the fourth. The highest total on the site, one point above Calibrate. The five points still available sit in rows that need a live visit on request (prescriber, two points), a phone or live support option (support), a shipped lot COA with a named laboratory (supply) and a state of licensure or licence reference for Recess MD LLC (licensure). Every one of those is a page FormBlends could publish tomorrow, and we would read it and log it here.
2026-09-05, third read: FormBlends, held at 18 of 24
What FormBlends published. Later again on September 5, 2026: the sentence "The price does not change with dose: it is the same at 2.5 mg or 15 mg. Your clinician sets the dose. Shipping is included; lab work is not." on the pricing page, the pharmacy-and-quality page and the price block of both product pages; "Lab work is not included; shipping is" in the pricing page's not-included list; every home page block changed from 47 to "36 States and territories served"; and the FormBlends-vs-Ro article's at-a-glance and cost tables corrected in the stored article body. FormBlends also told us that its cost calculator default now comes from the pricing module and that a replacement of a stale "$199/month" sentence across its experience-hub articles is in progress.
What we re-read, and how. All 24 pages in the evaluation's source list at about 20:45 UTC. Because the FormBlends-vs-Ro live page and the cost calculator were both served from cache (age under an hour), we also read the stored article body directly (NEW-00024_formblends-vs-ro.html in FormBlends' content store, linked from the evaluation's sources). We could not read a newer calculator build; we scored the page a reader sees.
| Criterion | Second read | Third read | Page | What changed, and why the score did or did not move |
|---|---|---|---|---|
| Licensure and state coverage | 2 | 2 | formblends.com (home); formblends.com/where-we-serve; formblends.com/pharmacy-and-quality | The 47 States served blocks are gone; every home page block reads 36 States and territories served. Held at 2: level 3 requires the medical group named with a state of licensure or a licence reference, and Recess MD LLC still has neither on any page. Same reading that holds Ro at 2. |
| Prescriber model | 1 | 1 | formblends.com/pharmacy-and-quality | No change to the live-visit sentence. Held at 1. |
| Pharmacy sourcing transparency | 3 | 3 | formblends.com/pharmacy-and-quality | No change. The dose sentence was added to this page but does not touch this row. |
| Pricing transparency | 2 | 2 | formblends.com/pricing; formblends.com/products/semaglutide; formblends.com/products/tirzepatide; formblends.com/tools/cost-calculator; stored body NEW-00024_formblends-vs-ro.html | Level 3 sentence now on the pricing page and product panels: The price does not change with dose: it is the same at 2.5 mg or 15 mg. Your clinician sets the dose. Shipping is included; lab work is not. With the dated introductory price, the renewal price per plan and the inclusions list, every element of the level 3 definition is on the pricing page. Held at 2 because other pages on the same site still state a different FormBlends price when read the same evening: the cost calculator card reads $199/mo; the provider chart row shared by the FormBlends comparison articles, including the corrected stored body of the vs-Ro article, reads FormBlends | 92 | From $299/mo, physician-led; the live vs-Ro page still showed $149/month and $149-$399 from cache (the stored body now reads $99 first month, then $190/month and First month $99 or $149; then $190 to $239 per month); and the cash price index still marks the recurring price not verified. Two live prices for one program is the reading that holds Noom Med at 2. The experience-hub sentence replacement was noted as in progress and not counted. |
| Refund and cancellation terms | 3 | 3 | formblends.com/returns | No change. |
| Medication supply chain and COA availability | 2 | 2 | formblends.com/pharmacy-and-quality | No change. COA still on request; laboratory still not named. |
| Support access | 2 | 2 | formblends.com/contact | No change. Still no phone or live option. |
| Privacy | 3 | 3 | formblends.com/privacy | No change. |
Totals. 18 of 24 on the second read; 18 of 24 on the third. Still level with Calibrate at the top of the twelve, with nothing scoring higher. What would move pricing to 3. One FormBlends price on every FormBlends page a reader can open: retire the calculator's $199 card, remove or correct the From $299/mo chart row, refresh the cash price index, and let the vs-Ro cache expire. When those are live we will read them and log it here.
2026-09-05, second read: FormBlends, 15 to 18 of 24
What FormBlends published. Later on September 5, 2026 (the date printed on the pages) formblends.com: named Recess MD LLC as the prescribing medical group on the where-we-serve, pharmacy-and-quality and about pages and in a new trust panel on both product pages; added a designation line to each named pharmacy and a "What 503A means for your medication" section; replaced the single price column with one-time and Subscribe & Save renewal columns and stated exact renewal prices; added a lost-shipment rule and shipping timelines to the returns and shipping pages; added a plain-language summary, a tracking and analytics section honouring Global Privacy Control, and retention and deletion terms to the privacy policy; added a callback request to the contact page; changed the terms' governing law from Delaware to Wyoming; marked liraglutide not currently available; changed the home hero to "dispensed in 36 states and territories"; and updated the FormBlends-vs-Ro article's body prices and its 503B sentence.
What we re-read. All 24 pages listed in the sources of the FormBlends evaluation, on 2026-09-05, including the pages that did not change.
| Criterion | First read | Second read | Page that justified the change or the hold | The sentence that satisfies the level, or the element still missing |
|---|---|---|---|---|
| Licensure and state coverage | 2 | 2 | formblends.com/where-we-serve; formblends.com/pharmacy-and-quality; formblends.com (home) | New: Prescriptions are written by independent, state-licensed clinicians (MD, DO, NP or PA) of Recess MD LLC, a medical group separate from Form Blends LLC. Held at 2: level 3 requires both the medical group and the pharmacy to be named with a state of licensure or a licence reference, and Recess MD LLC carries neither on any page (the clinician licence number appears on the prescription, after payment). Ro is held at 2 on the same reading. Also, two home page statistic blocks still read 47 States served while the hero reads 36. |
| Prescriber model | 1 | 1 | formblends.com/pharmacy-and-quality; product page trust panels | New: clinician type, the list of what the clinician reviews, and a check-in is requested before dose changes. Held at 1: the live-visit sentence is Where clinically needed, or where your state requires a synchronous encounter, the clinician may ask for a video or phone visit before prescribing. Level 2 requires a live visit available on request; no page says a patient can ask for one. |
| Pharmacy sourcing transparency | 2 | 3 | formblends.com/pharmacy-and-quality; formblends.com/products/semaglutide; formblends.com/products/tirzepatide | Designation lines: Greenwich RX 503A compounding pharmacy; The DrugStore on East State 503A compounding pharmacy; Chemistry Rx 503A compounding pharmacy and 503B outsourcing facility. Testing and beyond-use dating: A beyond-use date is assigned per the USP 797 category and printed on the label. Batch potency and sterility testing is available as a certificate of analysis on request. Brand distinction: Zepbound, Mounjaro, Wegovy and Ozempic are FDA-approved products made by Lilly and Novo Nordisk with FDA-reviewed manufacturing. Compounded semaglutide and compounded tirzepatide are not FDA approved, are not generic versions of those products, and are not interchangeable with them. Not-FDA-approved statement is on both product pages. Level 3 met. |
| Pricing transparency | 2 | 2 | formblends.com/pricing; formblends.com/articles/comparison-hub/formblends-vs-ro; formblends.com/tools/cost-calculator | New on the pricing page: Every plan is a one-time upfront charge for the plan length. Nothing renews unless you choose Subscribe & Save, with exact renewal prices per plan ($165, $374, $689, $1,163 semaglutide; $214, $602, $1,169, $2,123 tirzepatide), a dated introductory price, and inclusions and exclusions next to the price. The first-read month-two ambiguity is resolved. Held at 2: the FormBlends-vs-Ro at-a-glance table, on an article dated September 5, 2026, still shows a FormBlends starting price of $149 a month and a $149 to $399 range, the cost calculator still plans $199 a month, and no page says whether the price changes with dose. Two live pages disagreeing on price is the reading that holds Noom Med at 2. |
| Refund and cancellation terms | 2 | 3 | formblends.com/returns; formblends.com/shipping; formblends.com/pricing | Rule 4, new: If tracking shows no delivery 5 days after the carrier's expected date, email support@formblends.com with your order number. We open a carrier trace. Once the carrier confirms the loss, or after 10 business days without a delivery scan, whichever comes first, we reship at no charge or refund the order, your choice. With rule 1 (full refund if not prescribed), rule 3 (damaged or incorrect replaced within 7 days), rule 5 (cancel by email before the next billing date) and the link from the pricing page and both product pages, level 3 is met. |
| Medication supply chain and COA availability | 2 | 2 | formblends.com/pharmacy-and-quality | Unchanged in substance: You can request your lot's COA (potency and sterility results) and the pharmacy's state licence number from support at any time. Held at 2: level 3 requires lot COAs published or provided with each shipment, the testing laboratory identified and the active ingredient source described; none of the three is on any page. |
| Support access | 2 | 2 | formblends.com/contact | New: We do not run a phone line, but you can ask support to call you, through a callback request on the contact form that support confirms by email. Held at 2: the page still states There is no phone line; a callback arranged by email is not a phone or live option, and the only urgent route is call 911 or go to urgent care. |
| Privacy | 2 | 3 | formblends.com/privacy; formblends.com/hipaa | Plain-language summary: a section headed The short version covering what is collected, who sees it, how long it is kept and how to ask for access or deletion. Tracking opt-out: Global Privacy Control: if your browser sends a Global Privacy Control signal, we honor it. Google Analytics and advertising storage are set to denied, the Meta pixel is not loaded, and PostHog is opted out of capturing, with an email route for readers without a GPC signal. Retention and deletion: prescription records for the period state pharmacy law sets, and We respond within 30 days. Separate HIPAA notice published; no-sale and no-ad-targeting on health data stated. Level 3 met. Residual: the California notice still lists marketing partners as recipients. |
Totals. 15 of 24 on the first read of 2026-09-05; 18 of 24 on the second. Three rows moved up by one point each; five rows did not move. Among the twelve evaluations on this site, no program scores higher: Calibrate also scores 18; WeightWatchers Clinic 17; Ro and NovoCare Pharmacy 16; Hims & Hers and Found 15; Noom Med 14; Ivim Health and LillyDirect 13; Mochi Health 12; Henry Meds 11. FormBlends went from the lowest total on the site to level with the highest in two days, by publishing pages, and the people who scored it are the people who published them. The rubric is designed so that this is possible for any program, and the safeguard is not our judgement but yours: every row above quotes the sentence that earned it. Open the page. If the sentence is not there, or does not say what we say it says, write to hello@formblends.com and the row will be re-read and logged.
Not re-run. The regulatory record search was last run on 2026-09-04 and was not repeated. It does not move scores.
What would move the score again. The eight items under "what we would still like to see" on the FormBlends evaluation. The six points still available sit in rows that need a live visit on request (prescriber), a phone or live support option (support), a shipped lot COA with a named laboratory (supply), a state of licensure for Recess MD LLC (licensure), and one price list with no live page contradicting it (pricing).
2026-09-05, first read: FormBlends, 9 to 15 of 24
What FormBlends published. On September 5, 2026 (the date printed on the pages) formblends.com added a pricing page, a where-we-serve page and a pharmacy-and-quality page (the old /about/pharmacy-and-quality now redirects to it), rewrote its returns and contact pages, and updated its terms of service and privacy policy. The product pages gained a price block and links to the four new pages.
What we re-read. All 22 pages then listed in the sources of the FormBlends evaluation, on 2026-09-05, including the pages that did not change (HIPAA notice, California notice, telehealth consent, provider network, how it works, regulatory status, cost index, cost calculator and the FormBlends-vs-Ro article).
| Criterion | 2026-09-04 | 2026-09-05, first read | Page that justified the change | What the page stated, and why the score stopped where it did |
|---|---|---|---|---|
| Licensure and state coverage | 0 | 2 | formblends.com/where-we-serve; formblends.com/pharmacy-and-quality | The state page listed every state, DC and Puerto Rico as either dispensed to (36) or check at assessment (16). The pharmacy page named Greenwich RX (Greenwich Health & Wellness LLC, Tomball TX), The DrugStore on East State (Athens OH) and Chemistry Rx (Folcroft PA), linked state board lookups and offered the licence number on request. Level 2: states stated and pharmacy named, lookup possible. Not 3: no medical group was named on any page. Noted: the home page said 47 states served. |
| Prescriber model | 1 | 1 | formblends.com/telehealth-consent; formblends.com/where-we-serve; formblends.com/contact | Clinician type was now on public pages (MD, DO, NP, PA). Review was still asynchronous; a live video or phone visit was described only where a state requires one, and no page said a patient can request one. Level 1 still fit. No change. |
| Pharmacy sourcing transparency | 1 | 2 | formblends.com/pharmacy-and-quality; formblends.com/products/semaglutide; formblends.com/products/tirzepatide | Three pharmacies named; 503A and not-FDA-approved statements on both product pages. Level 2. Not 3: The DrugStore on East State carried no 503A or 503B designation of its own, the page did not explain what the designation means for testing or beyond-use dating, and the FormBlends-vs-Ro article still said 503B facilities. |
| Pricing transparency | 1 | 2 | formblends.com/pricing | Intro, monthly and 3, 6 and 12 month prices for semaglutide and tirzepatide, dated, inclusions listed, labs and outside care excluded. Level 2. Not 3: the page said then $190 per month and also renews at the plan price minus a $25 subscriber credit, so month two was $190 or $165; price by dose was not addressed; liraglutide ($199 on the products page) had no renewal terms; the cost calculator and the FormBlends-vs-Ro article still carried older prices. |
| Refund and cancellation terms | 1 | 2 | formblends.com/returns; formblends.com/pricing; formblends.com/shipping | Full refund if not prescribed, cancel by email before the next billing date, damaged, spoiled or incorrect shipments replaced within 7 days, an escalation route, and the policy linked from the pricing page and both product pages. Level 2 fully met. Not 3: lost shipments were not in the six rules and the shipping page only said support would route the request to a partner. |
| Medication supply chain and COA availability | 2 | 2 | formblends.com/pharmacy-and-quality | Testing described; lot COA and pharmacy licence number on request via support. Level 2 as before. Not 3: laboratory not identified, no lot COA published, active ingredient source not described. No change. |
| Support access | 1 | 2 | formblends.com/contact | Email and a web form with published hours (Mon to Fri 9 am to 6 pm ET), a two-business-hour reply target, a stated route for clinical questions (the treating provider through the patient portal) and an escalation route. Level 2. Not 3: the page stated there is no phone line and described no live option. |
| Privacy | 2 | 2 | formblends.com/privacy; formblends.com/hipaa; formblends.com/ccpa | The updated policy added named recipients of health data, retention terms and an email route for access, correction, deletion and do-not-sell; the HIPAA notice was separate; no sale and no advertising targeting on health data were stated. Level 2 as before. Not 3: no plain-language summary and no tracking opt-out beyond browser cookie settings. No change. |
Totals. 9 of 24 on 2026-09-04; 15 of 24 on the first read of 2026-09-05. Five rows moved up by a combined six points; three rows did not move.
2026-09-04: first publication
All twelve evaluations published on rubric v1.0 from public pages read on 2026-09-04. No prior scores.
Questions people ask
Why did FormBlends' total move ten points in two days?
Because the rubric scores disclosure, and on 2026-09-05 FormBlends published, in two rounds, the disclosures the rubric asks for: a state list, a named medical group, named pharmacies with their 503A or 503B status, a dated price list with exact renewal prices, a refund policy with not-prescribed, damaged and lost-shipment rules, a contact page with hours and a clinical route, and a privacy policy with a plain-language summary and a Global Privacy Control statement. The rows that measure those things moved. The rows that measure things FormBlends still does not publish (a live visit on request, a phone or live support option, a lot COA shipped with the order, a state of licensure for the medical group) did not.
Can any company raise its score by publishing new pages?
Yes, and that is the point. Email hello@formblends.com with the URL that changed and we re-read the whole reading list, not just that page. The change, the date and the page go in this log. FormBlends' own pages get no faster or slower treatment; the re-read dates on its evaluation are the dates the pages went live, which are also the dates we were told about them, because we are the same team. That is a conflict, and it is why every FormBlends row quotes the sentence that earned it.
FormBlends is now level with the highest total on the site. Does this site recommend FormBlends?
No. The site does not recommend anything and the totals are not a ranking. FormBlends' 19 of 24 is the highest total on the site, one point above Calibrate. It was produced by the people who write formblends.com, so read the FormBlends evaluation with more suspicion than the others, open the cited pages, and check each row yourself. Two rows were held at 2 on the same readings that hold Ro and Noom Med at 2; if you think that was the wrong call in either direction, the correction address is on every page.
Sources
16 references
- FormBlends: pricing Accessed September 5, 2026.
- FormBlends: where we serve Accessed September 5, 2026.
- FormBlends: pharmacy network, prescribers and quality Accessed September 5, 2026.
- FormBlends: returns, refunds and cancellation Accessed September 5, 2026.
- FormBlends: shipping policy Accessed September 5, 2026.
- FormBlends: contact Accessed September 5, 2026.
- FormBlends: terms of service (last updated September 5, 2026) Accessed September 5, 2026.
- FormBlends: privacy policy (last updated September 5, 2026) Accessed September 5, 2026.
- FormBlends: consent to telehealth Accessed September 5, 2026.
- FormScripts: telehealth consent naming Recess MD LLC Accessed September 5, 2026.
- FormBlends: compounded semaglutide Accessed September 5, 2026.
- FormBlends: compounded tirzepatide Accessed September 5, 2026.
- FormBlends: liraglutide (not currently available) Accessed September 5, 2026.
- FormBlends: home page Accessed September 5, 2026.
- FormBlends: cost calculator Accessed September 5, 2026.
- FormBlends article: FormBlends vs Ro (updated September 5, 2026) Accessed September 5, 2026.
Canonical URL: https://formblendsreviews.com/methodology/re-evaluations-and-change-log. Written by the FormBlends editorial team. This page is educational and is not medical advice; see the medical disclaimer.
